The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients.

Autor: Onoe, Hiromitsu¹ (AUTHOR) onoehir@hiroshima-u.ac.jp, Hirooka, Kazuyuki¹ (AUTHOR) khirooka9@gmail.com, Baba, Tetsuya² (AUTHOR) tbaba@shirai-hosp.or.jp, Nagayama, Mikio³ (AUTHOR) mikio@po.harenet.ne.jp, Hirota, Atsushi⁴ (AUTHOR) hirotaganka@lion.ocn.ne.jp, Suzuki, Katsuyoshi⁵ (AUTHOR) suzuki_eye@grace.ocn.ne.jp, Sagara, Takeshi⁶ (AUTHOR) tsagara65@gmail.com, Mochizuki, Hideki⁷ (AUTHOR) mochizuki-h@hiroshima-u.ac.jp, Kiuchi, Yoshiaki¹ (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Jul2024, Vol. 13 Issue 14, p4158. 8p.

Pharmaceutical Approaches to Normal Tension Glaucoma.

Autor: Salvetat, Maria Letizia¹ (AUTHOR), Pellegrini, Francesco¹ (AUTHOR), Spadea, Leopoldo² (AUTHOR), Salati, Carlo³ (AUTHOR), Zeppieri, Marco³ (AUTHOR) markzeppieri@hotmail.com

Publikováno v: Pharmaceuticals (14248247). Aug2023, Vol. 16 Issue 8, p1172. 29p.

Prediction of visual field progression in glaucoma: existing methods and artificial intelligence.

Autor: Asaoka, Ryo, Murata, Hiroshi

Publikováno v: Japanese Journal of Ophthalmology; Sep2023, Vol. 67 Issue 5, p546-559, 14p

Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study.

Autor: Tanihara H; Department of Ophthalmology, Biei Municipal Hospital, 3-8-35 Naka-machi, Biei Town, Kamikawa-gun, Hokkaido, 071-0207, Japan. tanihara@pearl.ocn.ne.jp., Yamamoto T; Prof. Kazuo Iwata Memorial Kaijin Glaucoma Center, Kaiya Eye Clinic, Shizuoka, Japan., Aihara M; Department of Ophthalmology, The University of Tokyo, Tokyo, Japan., Koizumi N; Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan., Fukushima A; Department of Ophthalmology, Tsukazaki Hospital, Hyogo, Japan., Kawakita K; Pharmaceutical Clinical Development Management Department, Kowa Company, Ltd., Tokyo, Japan., Kojima S; Pharmaceutical Clinical Development Management Department, Kowa Company, Ltd., Tokyo, Japan., Nakamura T; Medical Affairs Department, Kowa Company, Ltd., Tokyo, Japan., Suganami H; Data Science Center, Kowa Company, Ltd., Tokyo, Japan.

Publikováno v: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2024 Aug; Vol. 262 (8), pp. 2579-2591. Date of Electronic Publication: 2024 Mar 02.

Impact of glaucoma medications on subsequent Schlemm's canal surgery outcome: Cox proportional hazard model and propensity score-matched analysis.

Autor: Okuda-Arai M; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan., Mori S; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.; Institute of Ophthalmology, University College London, London, UK., Takano F; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan., Ueda K; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan., Sakamoto M; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan., Yamada-Nakanishi Y; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan., Nakamura M; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Publikováno v: Acta ophthalmologica [Acta Ophthalmol] 2024 Mar; Vol. 102 (2), pp. e178-e184. Date of Electronic Publication: 2023 Sep 12.